Search

everythinglearnresearchcommunity

for

Search:↓

Compound 4 is a promising treatment for hair loss with low toxicity.

TGF-β1 increases androgen receptor activity in hair loss, but Hic-5/ARA55 can counter this effect.

Finasteride doesn't improve survival in LNCaP tumor model during off-cycle of therapy.

Flutamide and a new synthetic steroid affected brain and prostate chemicals and showed potential for treating androgen-related conditions and epilepsy.

Decursin shows promise for treating cancer, neuroprotection, inflammation, and hair loss.

Certain spices may help prevent and treat skin cancer, but more human trials are needed.

Estrogen Receptor ß (ERß) is the main hormone controller in human skin and hair follicles, not Estrogen Receptor α (ERα) or the Androgen Receptor (AR).

Ganoderma lucidum may help treat enlarged prostate in rats.

The WNT signaling pathway is important in many diseases and targeting it could offer new treatments.

Two new compounds were found to build bone and muscle without affecting reproductive organs and skin oil glands.

SARMs may be an effective treatment for a certain type of breast cancer by blocking cancer growth and spread.

TGF-β is crucial for tissue repair and can cause diseases if not properly regulated.

New genes found linked to balding, may help develop future treatments.

Germacrone from Curcuma aeruginosa may help treat conditions related to male hormones by blocking a specific enzyme.

Different drugs for prostate-related urinary symptoms work but have various side effects, and treatment should be tailored to the individual.

Overexpression of sPLA2-IIA in mouse skin reduces hair stem cells and increases cell differentiation through JNK/c-Jun pathway activation.

New liposome treatment successfully delivers CRISPR to deactivate a key enzyme in androgen-related disorders.

The document concludes that targeting the androgen receptor may be a promising breast cancer treatment, especially for certain types.

Colorectal cancer development involves both genetic changes and epigenetic alterations like DNA methylation and microRNA changes.

High levels of ST14 and TMEFF1 proteins in ovarian cancer are linked to worse patient outcomes and may be a new treatment target.

Tissue-derived extracellular vesicles are crucial for cancer diagnosis, prognosis, and treatment.

Indian Gooseberry has potential for cancer prevention and treatment and promotes hair growth.

Blocking the androgen receptor in skin cells reduces their growth response to male hormones, suggesting a possible treatment for skin conditions linked to androgens.

Androgens slow hair growth by altering Wnt signaling in balding cells.

Scoparone may help stimulate hair growth by increasing stem cell-related proteins in skin cells.

Estrogen increases blood vessel growth factor production, while testosterone blocks this increase.

Certain human skin cells marked by CD44 and ALDH are rich in stem cells capable of long-term skin renewal.

Androgens may cause hair loss by increasing TGF-beta1 from scalp cells, which inhibits hair cell growth.

Prostaglandins and the enzyme AKR1C3 could play a role in skin cancer and hair loss, and further research is needed to understand these mechanisms.

The study found that women with hyperandrogenic PCOS have higher levels of AKT1 and AKT2 proteins in their cells, which may lead to cell dysfunction.